Literature DB >> 11779746

Steroids cause osteoporosis.

S Paget1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779746      PMCID: PMC1753875          DOI: 10.1136/ard.61.1.1-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  11 in total

1.  Slow evolution to systemic lupus erythematosus of isolated autoimmune thrombocytopenia.

Authors:  L Lepore; C M Salvatore; T Pahor; V Kiren; A Ventura
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

2.  Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.

Authors:  L J Walsh; C A Wong; M Pringle; A E Tattersfield
Journal:  BMJ       Date:  1996-08-10

3.  A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists.

Authors:  E Soucy; N Bellamy; J D Adachi; J E Pope; J Flynn; E Sutton; J Campbell
Journal:  J Rheumatol       Date:  2000-06       Impact factor: 4.666

4.  Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.

Authors:  D M Reid; R A Hughes; R F Laan; N A Sacco-Gibson; D H Wenderoth; S Adami; R A Eusebio; J P Devogelaer
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

5.  Is enough attention being given to the adverse effects of corticosteroid therapy?

Authors:  D M Hougardy; G M Peterson; M D Bleasel; C T Randall
Journal:  J Clin Pharm Ther       Date:  2000-06       Impact factor: 2.512

6.  Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice.

Authors:  B Gudbjornsson; U I Juliusson; F V Gudjonsson
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

7.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

Authors:  K G Saag; R Koehnke; J R Caldwell; R Brasington; L F Burmeister; B Zimmerman; J A Kohler; D E Furst
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

8.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

9.  Steroid induced osteoporosis: an opportunity for prevention?

Authors:  I D Peat; S Healy; D M Reid; S H Ralston
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

Review 10.  Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.

Authors:  S R Goldring; E M Gravallese
Journal:  Arthritis Res       Date:  1999-12-22
View more
  1 in total

1.  Muscle strength and bone density in patients with different rheumatic conditions: cross-sectional study.

Authors:  Selma Cvijetić; Simeon Grazio; Milica Gomzi; Ladislav Krapac; Tomislav Nemcić; Melita Uremović; Jasminka Bobić
Journal:  Croat Med J       Date:  2011-04-15       Impact factor: 1.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.